Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
In vitro selection of macrocyclic peptide inhibitors containing cyclic γ2,4-amino acids targeting the SARS-CoV-2 main protease
by
Terasaka, Naohiro
, Suga, Hiroaki
, Miura, Takashi
, Schofield, Christopher J
, Lukacik, Petra
, Walsh, Martin A
, Mikolajek, Halina
, Owen, C. David
, Strain-Damerell, Claire
, Malla, Tika R
, Salah, Eidarus
, Katoh, Takayuki
, Kawamura, Akane
, Brewitz, Lennart
, McDonough, Michael A
, Tumber, Anthony
in
Alanine
/ Amino acids
/ Binding
/ Carboxylic acids
/ COVID-19
/ Crystal structure
/ Inhibitors
/ Libraries
/ Natural products
/ Peptide inhibitors
/ Peptides
/ Protease
/ Proteinase
/ Proteolysis
/ Severe acute respiratory syndrome coronavirus 2
/ Stability
/ Substrate inhibition
2023
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
In vitro selection of macrocyclic peptide inhibitors containing cyclic γ2,4-amino acids targeting the SARS-CoV-2 main protease
by
Terasaka, Naohiro
, Suga, Hiroaki
, Miura, Takashi
, Schofield, Christopher J
, Lukacik, Petra
, Walsh, Martin A
, Mikolajek, Halina
, Owen, C. David
, Strain-Damerell, Claire
, Malla, Tika R
, Salah, Eidarus
, Katoh, Takayuki
, Kawamura, Akane
, Brewitz, Lennart
, McDonough, Michael A
, Tumber, Anthony
in
Alanine
/ Amino acids
/ Binding
/ Carboxylic acids
/ COVID-19
/ Crystal structure
/ Inhibitors
/ Libraries
/ Natural products
/ Peptide inhibitors
/ Peptides
/ Protease
/ Proteinase
/ Proteolysis
/ Severe acute respiratory syndrome coronavirus 2
/ Stability
/ Substrate inhibition
2023
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
In vitro selection of macrocyclic peptide inhibitors containing cyclic γ2,4-amino acids targeting the SARS-CoV-2 main protease
by
Terasaka, Naohiro
, Suga, Hiroaki
, Miura, Takashi
, Schofield, Christopher J
, Lukacik, Petra
, Walsh, Martin A
, Mikolajek, Halina
, Owen, C. David
, Strain-Damerell, Claire
, Malla, Tika R
, Salah, Eidarus
, Katoh, Takayuki
, Kawamura, Akane
, Brewitz, Lennart
, McDonough, Michael A
, Tumber, Anthony
in
Alanine
/ Amino acids
/ Binding
/ Carboxylic acids
/ COVID-19
/ Crystal structure
/ Inhibitors
/ Libraries
/ Natural products
/ Peptide inhibitors
/ Peptides
/ Protease
/ Proteinase
/ Proteolysis
/ Severe acute respiratory syndrome coronavirus 2
/ Stability
/ Substrate inhibition
2023
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
In vitro selection of macrocyclic peptide inhibitors containing cyclic γ2,4-amino acids targeting the SARS-CoV-2 main protease
Journal Article
In vitro selection of macrocyclic peptide inhibitors containing cyclic γ2,4-amino acids targeting the SARS-CoV-2 main protease
2023
Request Book From Autostore
and Choose the Collection Method
Overview
γ-Amino acids can play important roles in the biological activities of natural products; however, the ribosomal incorporation of γ-amino acids into peptides is challenging. Here we report how a selection campaign employing a non-canonical peptide library containing cyclic γ2,4-amino acids resulted in the discovery of very potent inhibitors of the SARS-CoV-2 main protease (Mpro). Two kinds of cyclic γ2,4-amino acids, cis-3-aminocyclobutane carboxylic acid (γ1) and (1R,3S)-3-aminocyclopentane carboxylic acid (γ2), were ribosomally introduced into a library of thioether-macrocyclic peptides. One resultant potent Mpro inhibitor (half-maximal inhibitory concentration = 50 nM), GM4, comprising 13 residues with γ1 at the fourth position, manifests a 5.2 nM dissociation constant. An Mpro:GM4 complex crystal structure reveals the intact inhibitor spans the substrate binding cleft. The γ1 interacts with the S1′ catalytic subsite and contributes to a 12-fold increase in proteolytic stability compared to its alanine-substituted variant. Knowledge of interactions between GM4 and Mpro enabled production of a variant with a 5-fold increase in potency.In vitro screening of a ribosomally synthesized macrocyclic peptide library containing cyclic γ2,4-amino acids (cγAA) afforded the discovery of potent inhibitors of the SARS-CoV-2 main protease (Mpro). A co-crystal structure revealed the contribution of this cγAA to Mpro binding and the proteolytic stability of these macrocycles.
Publisher
Nature Publishing Group
MBRLCatalogueRelatedBooks
Related Items
Related Items
We currently cannot retrieve any items related to this title. Kindly check back at a later time.
This website uses cookies to ensure you get the best experience on our website.